| [1] |
Wang L，Gao P，Zhang M，et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013[J].JAMA，2017，317(24)：2515-2523.
|
| [2] |
中华医学会糖尿病学分会，中华医学会感染病学分会，中华医学会组织修复与再生分会．中国糖尿病足防治指南(2019版)(Ⅰ)[J] .中华糖尿病杂志，2019, 11(2)：92-108.
|
| [3] |
Armstrong DG，Boulton AJM，Bus SA.Diabetic foot ulcers and their recurrence[J].N Engl J Med，2017，376(24)：2367-2375.
|
| [4] |
Jiang Y，Ran X，Jia L，et al.Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China[J].Int J Low Extrem Wounds，2015，14(1)：19-27.
|
| [5] |
Hicks CW，Selvarajah S，Mathioudakis N，et al.Burden of infected diabetic foot ulcers on hospital admissions and costs[J].Ann Vasc Surg，2016，33：149-158.
|
| [6] |
Schaper NC，van Netten JJ，Apelqvist J，et al.Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update)[J].Diabetes Metab Res Rev，2020，36 Suppl 1：e3266.
|
| [7] |
Saeed K，Esposito S，Akram A，et al.Hot topics in diabetic foot infection[J]. Int J Antimicrob Agents，2020，55(6)：105942.
|
| [8] |
Uckay I，Vernaz-Hegi N，Harbarth S，et al.Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit[J].J Infect，2009，58(3)：205-212.
|
| [9] |
Rieg S，Kupper MF.Infectious diseases consultations can make the difference：a brief review and a plea for more infectious diseases specialists in Germany[J].Infection，2016，44(2)：159-166.
|
| [10] |
Raineri E，Pan A，Mondello P，et al.Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit[J].Am J Infect Control，2008, 36(4)：283-290.
|
| [11] |
Robinson JO，Pozzi-Langhi S，Phillips M，et al.Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia[J].Eur J Clin Microbiol Infect Dis，2012，31(9)：2421-2428.
|
| [12] |
Barlam TF，Cosgrove SE，Abbo LM，et al.Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America[J].Clin Infect Dis，2016，62(10)：e51-e77.
|
| [13] |
Zhou Y，Ma LY，Zhao X，et al.Impact of pharmacist intervention on antibiotic use and prophylactic antibiotic use in urology clean operations[J].J Clin Pharm Ther，2015，40(4)：404-408.
|
| [14] |
Yang P，Jiang SP，Lu XY.Effectiveness of continuous improve-ment by a clinical pharmacist-led guidance team on the prophylactic antibiotics usage rationality in intervention procedure at a Chinese tertiary teaching hospital[J].Ther Clin Risk Manag，2017，13：469-476.
|
| [15] |
Chai W，Wang Y，Zheng H，et al.The profile of microbiological pathogens in diabetic foot ulcers[J].Front Med，2021，8：656467.
|
| [16] |
Barshes NR，Rodriguez-Barradas MC，Bechara CF，et al.Microbial isolates and their antimicrobial susceptibilities in inframalleolar foot infections[J].Surg Infect，2014，15(5)：585-591.
|
| [17] |
Li X，Qi X，Yuan G，et al.Microbiological profile and clinical characteristics of diabetic foot infection in northern China：a retrospective multicentre survey in the Beijing area[J].J Med Microbiol，2018，67(2)：160-168.
|
| [18] |
Wang J，Wang P，Wang X，et al.Use and prescription of antibiotics in primary health care settings in China[J].JAMA Intern Med，2014，174(12)：1914-1920.
|
| [19] |
Li H, Yan S，Li D，et al.Trends and patterns of outpatient and inpatient antibiotic use in China′s hospitals: data from the Center for Antibacterial Surveillance, 2012-16[J].J Antimicrob Chemother，2019，74(6)：1731-1740.
|
| [20] |
Lipsky BA，Berendt AR，Cornia PB，et al.2012 infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections[J].Clin Infect Dis，2012，54(12)：e132-e173.
|
| [21] |
Valiquette L，Cossette B，Garant MP，et al.Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain[J].Clin Infect Dis，2007，45 Suppl 2：S112-S121.
|
| [22] |
Price J，Cheek E，Lippett S，et al.Impact of an intervention to control clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis[J].Clin Microbiol Infect, 2010，16(8)：1297-1302.
|
| [23] |
Aldeyab MA，Kearney MP，Scott MG，et al.An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of clostridium difficile infection in hospital settings[J].J Antimicrob Chemother，2012，67(12)：2988-2996.
|
| [24] |
Wang N，Yang BH，Wang G，et al.A meta-analysis of the relationship between foot local characteristics and major lower extremity amputation in diabetic foot patients[J].J Cell Biochem，2019，120(6)：9091-9096.
|
| [25] |
Nather A, Siok Bee C，Keng Lin W，et al.Value of team approach combined with clinical pathway for diabetic foot problems：a clinical evaluation[J].Diabet Foot Ankle，2010，1(1)：5731.
|
| [26] |
Martínez-Gómez D, Moreno-Carrillo MA，Campillo-Soto A，et al.Reduction in diabetic amputations over 15 years in a defined Spain population.Benefits of a critical pathway approach and multidisciplinary team work[J].Rev Esp Quimioter，2014，27(3)：170-179.
|
| [27] |
Peters EJG, Lipsky BA，Senneville É，et al.Interventions in the management of infection in the foot in diabetes：a systematic review[J]. Diabetes Metab Res Rev，2020，36，Suppl 1：e3282.
|